Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan women.

Genetic polymorphisms of the Fc gamma receptors (FcγR) IIa and IIIa have been implicated in the rate of HIV-1 disease progression, but results are inconsistent. We aimed to determine the association between these polymorphisms and disease progression in a cohort of HIV-1 seroconverters from Mombasa, Kenya. Neither FcγRIIa nor FcγRIIIa genotypes were predictive of set point viral load, viral load increase, CD4 decline, or HIV-1 disease progression (time to CD4 count <200 cells/mm(3), death, or treatment initiation). Our results suggest that FcγR polymorphisms might not be an important indicator of viral control and disease progression in this population.

[1]  James Y. Dai,et al.  FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. , 2014, The Journal of clinical investigation.

[2]  N. Letvin,et al.  Natural Killer cell-dependent and non-dependent anti-viral activity of 2-Cys Peroxiredoxin against HIV. , 2013, International trends in immunity.

[3]  M. Robert-Guroff,et al.  Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention. , 2013, Current HIV research.

[4]  P. Burchard,et al.  Detection of the FCGR3a polymorphism using a real-time polymerase chain reaction assay. , 2013, Cancer genetics.

[5]  D. Irvine,et al.  Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b , 2013, Journal of Virology.

[6]  K. Hong,et al.  Impaired natural killer cell‐induced antibody‐dependent cell‐mediated cytotoxicity is associated with human immunodeficiency virus‐1 disease progression , 2013, Clinical and experimental immunology.

[7]  C. Pauza,et al.  High Affinity Allele for the Gene of FCGR3A Is Risk Factor for HIV Infection and Progression , 2010, PloS one.

[8]  Cheng Zhu,et al.  Dynamics of the Interaction of Human IgG Subtype Immune Complexes with Cells Expressing R and H Allelic Forms of a Low-Affinity Fcγ Receptor CD32A1 , 2009, The Journal of Immunology.

[9]  D. Forthal,et al.  Fc receptor-mediated antiviral antibodies , 2009, Current opinion in HIV and AIDS.

[10]  H. Liao,et al.  Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers , 2009, AIDS.

[11]  P. Bruhns,et al.  Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. , 2009, Blood.

[12]  F. Kurreeman,et al.  Contribution of Fcγ receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis , 2008, Annals of the rheumatic diseases.

[13]  G. Landucci,et al.  FcγRIIa Genotype Predicts Progression of HIV Infection1 , 2007, The Journal of Immunology.

[14]  J. Vulule,et al.  Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children. , 2006, The American journal of tropical medicine and hygiene.

[15]  Y. Komiyama,et al.  Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. , 2005, Journal of clinical immunology.

[16]  Kimberly C. Brouwer,et al.  Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection , 2004, AIDS.

[17]  J. Baeten,et al.  Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. , 2004, The Journal of infectious diseases.

[18]  L. V. D. van de Putte,et al.  Role of Fcgamma receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis. , 2003, The Journal of rheumatology.

[19]  J. Baeten,et al.  Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. V. Ravetch,et al.  IgG Fc receptors. , 2001, Annual review of immunology.

[21]  L. Jagodzinski,et al.  Evaluation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay Using Primary Subtype A, C, and D Isolates from Kenya , 2000, Journal of Clinical Microbiology.

[22]  S. Steinberg,et al.  Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men. , 2000, Blood.

[23]  B. Richardson,et al.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.

[24]  S. Moses,et al.  Preparation for AIDS vaccine evaluation in Mombasa, Kenya: establishment of seronegative cohorts of commercial sex workers and trucking company employees. , 1994, AIDS research and human retroviruses.

[25]  J. V. D. van de Winkel,et al.  A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. , 1991, Journal of immunology.

[26]  R. Kimberly,et al.  A single amino acid distinguishes the high‐responder from the low‐responder form of Fc receptor II on human monocytes , 1991, European journal of immunology.

[27]  N. Stollman,et al.  Molecular basis for a polymorphism involving Fc receptor II on human monocytes. , 1989, Journal of immunology.